Atyr Pharma's other current assets is $42M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Atyr Pharma (LIFE) currently reports a other current assets of $42M as of June 2026. That compares with $70M in the prior-year period — down 40.1% year over year. Use the charts on this page to explore Atyr Pharma's other current assets history and peer comparisons.
Atyr Pharma's other current assets decreased from $70M to $42M — a 40.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Atyr Pharma reported $42M in other current assets as of June 2026. That compares with $70M in the prior-year period — down 40.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current other current assets of $42M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Atyr Pharma, and consider following LIFE for alerts when major investors trade the stock.
Atyr Pharma is classified in the Healthcare sector. On other current assets, it currently shows $42M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LIFE with unrelated industries.